apnea has been researched along with Birth Weight in 153 studies
Apnea: A transient absence of spontaneous respiration.
Birth Weight: The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
Excerpt | Relevance | Reference |
---|---|---|
"Methylxanthines, including caffeine, theophylline, and aminophylline, work as stimulants of the respiratory drive, and decrease apnea of prematurity, a developmental disorder common in preterm infants." | 9.41 | Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants. ( Bruschettini, M; Marques, KA; Moresco, L; Sjögren, A; Soll, R, 2023) |
"Preterm infants with apnea who were born at less than 32 weeks of gestational age and birth weight ≤1500 g were randomly divided into caffeine citrate prevention group and caffeine citrate treatment group." | 9.34 | Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea. ( Gao, Z; Han, D; Kou, C; Li, Z; Liu, Z; Wu, W; Zhang, Y, 2020) |
"Caffeine therapy for apnea of prematurity did not significantly reduce the combined rate of academic, motor, and behavioral impairments but was associated with a reduced risk of motor impairment in 11-year-old children with very low birth weight." | 9.24 | Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial. ( Anderson, PJ; Asztalos, EV; Costantini, L; D'Ilario, J; Davis, PG; Dewey, D; Doyle, LW; Grunau, RE; Moddemann, D; Nelson, H; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W, 2017) |
" This low-cost neuromodulatory procedure has the potential to provide a non-invasive intervention to reduce apnea, bradycardia and intermittent hypoxia in premature neonates." | 9.22 | Neuromodulation of Limb Proprioceptive Afferents Decreases Apnea of Prematurity and Accompanying Intermittent Hypoxia and Bradycardia. ( Benharash, P; Cordero, DM; Frank, P; Harper, RM; Kesavan, K, 2016) |
"To evaluate the effectiveness and safety of different doses of caffeine in treatment of primary apnea in preterm infants." | 9.22 | [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants]. ( Liu, G; Tian, X; Zhao, Y, 2016) |
" Apneic events and bradycardia did not occur in the low-dose group; however, there were three episodes of apnea (42." | 9.19 | A comparative study of two remifentanil doses for procedural pain in ventilated preterm infants: a randomized, controlled study*. ( Choi, JH; Choi, KY; Kim, EK; Kim, HS; Lee, J; Lee, JH; Park, MS; Shin, SH, 2014) |
"Fifteen infants, median gestational age at birth 27 weeks (range 24-30), age at study 27 days (12-60), with >/=6 episodes of bradycardia or hypoxaemia/6 h despite serum caffeine levels in the therapeutic range, received doxapram either intravenously (0." | 9.09 | Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants. ( Bohnhorst, B; Darraj, S; Poets, CF, 1999) |
"Controversy exists as to the risk for postoperative apnea in former preterm infants." | 9.08 | Postoperative apnea in former preterm infants after inguinal herniorrhaphy. A combined analysis. ( Coté, CJ; Downes, JJ; Kurth, CD; Malviya, SV; Warner, LO; Welborn, LG; Zaslavsky, A, 1995) |
"To assess if there was any advantage in the prophylactic use of theophylline to prevent apnea in preterms, we treated 56 preterms (Group A) < 34 weeks gestation with theophylline infusion and compared these with 25 age and weight matched preterms (Group B) who received no therapy." | 9.07 | Prophylactic theophylline infusion for prevention of apnea of prematurity. ( Ashavaid, TF; Merchant, RH; Sakhalkar, VS, 1992) |
"To investigate claims that oscillating mattresses reduce apnea of prematurity and improve growth and neurobehavioural development, we performed a randomized clinical trial using a predetermined sample size." | 9.06 | Randomized clinical trial of an oscillating air mattress in preterm infants: effect on apnea, growth, and development. ( Campbell, D; Saigal, S; Watts, J, 1986) |
"19 infants admitted with a diagnosis of infantile apnea who were found to have periodic breathing were given oral theophylline to determine its effect." | 9.05 | An evaluation of theophylline for idiopathic apnea of infancy. ( Coward, JH; Duffley, LM; Finer, NN; Peters, KL, 1984) |
"It has been suggested that idiopathic apnea of prematurity is related to hypoxia from pulmonary instability or an immaturity of central respiratory control mechanisms." | 9.04 | Apnea of prematurity. Comparative therapeutic effects of cutaneous stimulation and nasal continuous positive airway pressure. ( Fanaroff, AA; Katona, PG; Kattwinkel, J; Klaus, MH; Nearman, HS, 1975) |
" It is thanks to the efforts of Barbara Schmidt and the Caffeine for Apnea of Prematurity (CAP) Trial Group that we now have high-quality and reliable data not only on short-term but also long-term outcomes of caffeine use for apnea of prematurity." | 8.90 | Caffeine for apnea of prematurity: a neonatal success story. ( Bassler, D; Kreutzer, K, 2014) |
" Percentage total sleep time (%TST) with respiratory events (isolated apneas, sequential apneas and periodic breathing (PB)) at each study was calculated." | 8.31 | Developmental consequences of short apneas and periodic breathing in preterm infants. ( Horne, RSC; Nixson, GM; Siriwardhana, LS; Walter, LM; Wong, FY; Yee, AK, 2023) |
"5 million babies born prematurely, and up to 40% of them are babies with low birth weights, highly prone to a multitude of diseases such as Jaundice, Sepsis, Apnea, and other Metabolic disorders." | 7.91 | Optimizing neural networks for medical data sets: A case study on neonatal apnea prediction. ( Acharya U, D; Lewis U, LES; M, S; Makkithaya, K; Shirwaikar, RD; Srivastava, S, 2019) |
"The factors affecting the safety and efficacy of aminophylline use in the treatment of apnea of prematurity (AOP) in the neonatal intensive care unit (NICU) are not clear." | 7.91 | Factors affecting the efficacy and safety of aminophylline in treatment of apnea of prematurity in neonatal intensive care unit. ( Dong, Z; Lu, X; Lyu, Q; Mao, Y; Miao, C; Ye, C; Yu, L; Zhang, J, 2019) |
"Incidence fell from 74% diagnosed with apnea of prematurity at baseline to 49% diagnosed with CSCPE postimplementation (P<0." | 7.85 | Clinically significant cardiopulmonary events and the effect of definition standardization on apnea of prematurity management. ( Ahlers-Schmidt, CR; Bloom, BT; Engel, M; Powell, MB, 2017) |
"This study evaluated the optimal timing for repair, incarceration risk, and postoperative apnea rate in premature infants with inguinal hernias." | 7.77 | A critical review of premature infants with inguinal hernias: optimal timing of repair, incarceration risk, and postoperative apnea. ( Gleason, JM; Lee, SL; Sydorak, RM, 2011) |
"Clinically relevant apneas, which are common in preterm infants, may adversely affect later neuropsychological condition in this group of patients." | 7.75 | Differential diagnosis of apneas in preterm infants. ( Dittrichová, J; Melichar, J; Miletín, J; Paul, K, 2009) |
"Adverse cardiorespiratory events including apnea, bradycardia, and desaturations have been described following administration of the first diphtheria-tetanus-pertussis-inactivated polio-Haemophilus influenzae type B (DTP-IPV-Hib) immunization to preterm infants." | 7.73 | Frequency of apnea, bradycardia, and desaturations following first diphtheria-tetanus-pertussis-inactivated polio-Haemophilus influenzae type B immunization in hospitalized preterm infants. ( Lee, J; Robinson, JL; Spady, DW, 2006) |
"Apnea of prematurity develop during the first days of life and usually resolve by the time the infant reaches 36-37 weeks postmenstrual age." | 7.73 | [Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate]. ( Baudon, JJ; Biran-Mucignat, V; Boelle, PY; Ducrocq, S; Gold, F; Lebas, F, 2006) |
"To identify current factors associated with home apnea monitor use in preterm infants and to determine whether home monitor use was associated with a shorter length of hospital stay." | 7.71 | Home apnea monitor use in preterm infants discharged from newborn intensive care units. ( Clark, R; Dodd, E; Peabody, J; Perfect Sychowski, S; Thomas, P, 2001) |
"Apnea of prematurity is common and none of the treatments being used are fully effective and free of significant adverse side effects." | 7.71 | Inhalation of low (0.5%-1.5%) CO2 as a potential treatment for apnea of prematurity. ( Al-Aif, S; Alvaro, R; Cates, D; Kwiatkowski, K; Manfreda, J; Rigatto, H, 2001) |
"Premature infants need to attain both medical stability and maturational milestones (specifically, independent thermoregulation, resolution of apnea of prematurity, and the ability to feed by mouth) before safe discharge to home." | 7.71 | Inter-neonatal intensive care unit variation in discharge timing: influence of apnea and feeding management. ( Blackwell, M; Eichenwald, EC; Lloyd, JS; Richardson, DK; Tran, T; Wilker, RE, 2001) |
" This study was designed to test the hypothesis that recurrent central apneas in preterm infants are correlated with a reduced prostacyclin to thromboxane A2 ratio." | 7.70 | Reduced prostacyclin to thromboxane A2 ratio is correlated with central apneas in preterm infants. ( Bernhard, M; Hoch, B, 1999) |
"Recordings of breathing movements and heart rate (pneumograms) were obtained prospectively in 89 preterm infants at 0-28 days of age to determine if those who develop apnea and/or bradycardia with cyanosis (Group 1) differ from those who do not (Group 2)." | 7.68 | Prospective pneumogram recordings in preterm infants with and without clinical apnea and bradycardia. ( Kelly, DH; McCulloch, KM, 1990) |
"The occurrence of central apnea of 15 seconds or longer, transient episodes of bradycardia (TEB), and periodic breathing were studied in 66 healthy premature infants when at least 1 week old and between 32 and 36 weeks postconceptual age." | 7.68 | Apnea, transient episodes of bradycardia, and periodic breathing in preterm infants. ( Cabal, LA; Gonzalez, F; Hodgman, JE; Hoppenbrouwers, T, 1990) |
"Apnea, bradycardia, and neuromuscular hyperirritability have been associated with magnesium (Mg) deficiency in young human infants and weanling animals." | 7.67 | Magnesium therapy in premature neonates with apnea neonatorum. ( Caddell, JL, 1988) |
"To determine the relationship of electrocardiographic changes to both intraventricular hemorrhage (IVH) and neonatal apnea, continuous electrocardiographic monitoring, serial electrocardiograms, and cranial echoencephalograms were obtained on 41 consecutive preterm neonates with birth weight below 1,250 g." | 7.67 | The electrocardiogram in preterm infants with intraventricular hemorrhage and apnea. ( Colavita, RD; Ment, LR, 1986) |
"To evaluate the relationship of antecedent maternal smoking and caffeine consumption habits on the occurrence of apnea in their offspring, rates for central and obstructive apnea were analyzed in a cohort of mother-infant pairs." | 7.67 | Effects of maternal smoking and caffeine habits on infantile apnea: a retrospective study. ( Bendell, D; Duke, JC; Mattice, CD; McCaffree, MA; Orr, WC; Toubas, PL, 1986) |
"Twelve premature infants with significant apnea of prematurity while receiving therapeutic doses of aminophylline were given an intravenous infusion of doxapram, 2 or 2." | 7.67 | Physiologic effects of doxapram in idiopathic apnea of prematurity. ( Barrington, KJ; Barton, J; Finer, NN; Peters, KL, 1986) |
"The efficacy of theophylline in preventing severe apnea was evaluated in 17 low-birthweight infants (mean weight, 1,400 gm)." | 7.65 | Prevention of apnea and bradycardia in low-birthweight infants. ( Gotay, F; Moylan, FM; Rogers, MC; Shannon, DC; Stein, IM; Todres, ID, 1975) |
" No over-all pattern relating sleep state to frequency of apnea could be detected for individual infants." | 7.65 | Sleep state, apnea and bradycardia in pre-term infants. ( Auld, PA; Krauss, AN; Solomon, GE, 1977) |
"Methylxanthines, including caffeine, theophylline, and aminophylline, work as stimulants of the respiratory drive, and decrease apnea of prematurity, a developmental disorder common in preterm infants." | 5.41 | Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants. ( Bruschettini, M; Marques, KA; Moresco, L; Sjögren, A; Soll, R, 2023) |
"Preterm infants with apnea who were born at less than 32 weeks of gestational age and birth weight ≤1500 g were randomly divided into caffeine citrate prevention group and caffeine citrate treatment group." | 5.34 | Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea. ( Gao, Z; Han, D; Kou, C; Li, Z; Liu, Z; Wu, W; Zhang, Y, 2020) |
"Caffeine therapy for apnea of prematurity did not significantly reduce the combined rate of academic, motor, and behavioral impairments but was associated with a reduced risk of motor impairment in 11-year-old children with very low birth weight." | 5.24 | Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial. ( Anderson, PJ; Asztalos, EV; Costantini, L; D'Ilario, J; Davis, PG; Dewey, D; Doyle, LW; Grunau, RE; Moddemann, D; Nelson, H; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W, 2017) |
" There were no statistical differences in episodes of feed interruption, number of infants with apnea, feed intolerance or diagnosis of sepsis." | 5.24 | Randomized Controlled Trial of Slow Versus Rapid Enteral Feeding Advancements on the Clinical Outcomes in Very Low Birth Weight Neonates. ( Ahmed, F; Dey, AC; Dey, SK; Hasan, Z; Jahan, I; Mannan, MA; Nahar, N; Shahidullah, M, 2017) |
"To evaluate the effectiveness and safety of different doses of caffeine in treatment of primary apnea in preterm infants." | 5.22 | [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants]. ( Liu, G; Tian, X; Zhao, Y, 2016) |
" This low-cost neuromodulatory procedure has the potential to provide a non-invasive intervention to reduce apnea, bradycardia and intermittent hypoxia in premature neonates." | 5.22 | Neuromodulation of Limb Proprioceptive Afferents Decreases Apnea of Prematurity and Accompanying Intermittent Hypoxia and Bradycardia. ( Benharash, P; Cordero, DM; Frank, P; Harper, RM; Kesavan, K, 2016) |
" The occurrence of apnea, progression of respiratory distress, nose bleeding, and agitation was defined as ventilation failure." | 5.20 | Response of Preterm Infants to 2 Noninvasive Ventilatory Support Systems: Nasal CPAP and Nasal Intermittent Positive-Pressure Ventilation. ( Brunherotti, MA; Leonardi, KM; Melo, AP; Silveira, CS; Zaia, JE, 2015) |
" Apneic events and bradycardia did not occur in the low-dose group; however, there were three episodes of apnea (42." | 5.19 | A comparative study of two remifentanil doses for procedural pain in ventilated preterm infants: a randomized, controlled study*. ( Choi, JH; Choi, KY; Kim, EK; Kim, HS; Lee, J; Lee, JH; Park, MS; Shin, SH, 2014) |
" Recording monitors were used continuously during the next 48 hours to document prolonged apnea and prolonged bradycardia." | 5.13 | Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study. ( Carbone, T; Karamchandani, N; Kelly, D; Kissin, D; McEntire, B; Steinschneider, A; Violaris, K, 2008) |
" Secondary outcomes included change in oxygen use and frequency of apnea and bradycardias postextubation." | 5.12 | Nasal continuous positive airway pressure from high flow cannula versus Infant Flow for Preterm infants. ( Campbell, DM; Kelly, EN; Shah, PS; Shah, V, 2006) |
" The most common cause of extubation failure was apnea/bradycardia." | 5.10 | A randomized, controlled trial comparing two different continuous positive airway pressure systems for the successful extubation of extremely low birth weight infants. ( Aschner, JL; Fuloria, M; Hansell, BJ; Morgan, TM; Murphy, WP; Stefanescu, BM, 2003) |
"Fifteen infants, median gestational age at birth 27 weeks (range 24-30), age at study 27 days (12-60), with >/=6 episodes of bradycardia or hypoxaemia/6 h despite serum caffeine levels in the therapeutic range, received doxapram either intravenously (0." | 5.09 | Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants. ( Bohnhorst, B; Darraj, S; Poets, CF, 1999) |
"Preterm infants with a gestational age of <32 weeks and birth weight of <1,500 g were randomized to receive either caffeine or aminophylline treatment for apnea of prematurity." | 5.09 | Brain hemodynamic changes in preterm infants after maintenance dose caffeine and aminophylline treatment. ( Bertini, G; Dani, C; Martelli, E; Reali, MF; Rubaltelli, FF; Tronchin, M; Wiechmann, L, 2000) |
"Controversy exists as to the risk for postoperative apnea in former preterm infants." | 5.08 | Postoperative apnea in former preterm infants after inguinal herniorrhaphy. A combined analysis. ( Coté, CJ; Downes, JJ; Kurth, CD; Malviya, SV; Warner, LO; Welborn, LG; Zaslavsky, A, 1995) |
"To assess if there was any advantage in the prophylactic use of theophylline to prevent apnea in preterms, we treated 56 preterms (Group A) < 34 weeks gestation with theophylline infusion and compared these with 25 age and weight matched preterms (Group B) who received no therapy." | 5.07 | Prophylactic theophylline infusion for prevention of apnea of prematurity. ( Ashavaid, TF; Merchant, RH; Sakhalkar, VS, 1992) |
"To investigate claims that oscillating mattresses reduce apnea of prematurity and improve growth and neurobehavioural development, we performed a randomized clinical trial using a predetermined sample size." | 5.06 | Randomized clinical trial of an oscillating air mattress in preterm infants: effect on apnea, growth, and development. ( Campbell, D; Saigal, S; Watts, J, 1986) |
"5, or (3) apnea associated with a heart rate less than 100 beats per minute that required frequent stimulation (more than 20 episodes during a 16-hour period)." | 5.06 | Theophylline treatment in the extubation of infants weighing less than 1,250 grams: a controlled trial. ( Ballard, RA; Clyman, RI; Durand, DJ; Goodman, A; Ray, P, 1987) |
"19 infants admitted with a diagnosis of infantile apnea who were found to have periodic breathing were given oral theophylline to determine its effect." | 5.05 | An evaluation of theophylline for idiopathic apnea of infancy. ( Coward, JH; Duffley, LM; Finer, NN; Peters, KL, 1984) |
"It has been suggested that idiopathic apnea of prematurity is related to hypoxia from pulmonary instability or an immaturity of central respiratory control mechanisms." | 5.04 | Apnea of prematurity. Comparative therapeutic effects of cutaneous stimulation and nasal continuous positive airway pressure. ( Fanaroff, AA; Katona, PG; Kattwinkel, J; Klaus, MH; Nearman, HS, 1975) |
" It is thanks to the efforts of Barbara Schmidt and the Caffeine for Apnea of Prematurity (CAP) Trial Group that we now have high-quality and reliable data not only on short-term but also long-term outcomes of caffeine use for apnea of prematurity." | 4.90 | Caffeine for apnea of prematurity: a neonatal success story. ( Bassler, D; Kreutzer, K, 2014) |
" Percentage total sleep time (%TST) with respiratory events (isolated apneas, sequential apneas and periodic breathing (PB)) at each study was calculated." | 4.31 | Developmental consequences of short apneas and periodic breathing in preterm infants. ( Horne, RSC; Nixson, GM; Siriwardhana, LS; Walter, LM; Wong, FY; Yee, AK, 2023) |
" The most common milestone sequence was CPAP discontinuation, caffeine discontinuation, thermoregulation, apnea resolution, and full oral feeds." | 4.12 | Achievement of maturational milestones among very low birth weight infants. ( Ahmad, SM; Fairchild, KD; Sinkin, RA; Slevin, CC; Sullivan, BA, 2022) |
"5 million babies born prematurely, and up to 40% of them are babies with low birth weights, highly prone to a multitude of diseases such as Jaundice, Sepsis, Apnea, and other Metabolic disorders." | 3.91 | Optimizing neural networks for medical data sets: A case study on neonatal apnea prediction. ( Acharya U, D; Lewis U, LES; M, S; Makkithaya, K; Shirwaikar, RD; Srivastava, S, 2019) |
"Doxapram is a treatment option for severe apnea of prematurity (AOP)." | 3.91 | Doxapram Treatment and Diaphragmatic Activity in Preterm Infants. ( de Jongh, FH; de Waal, CG; Hutten, GJ; Kraaijenga, JV; van Kaam, AH, 2019) |
"The factors affecting the safety and efficacy of aminophylline use in the treatment of apnea of prematurity (AOP) in the neonatal intensive care unit (NICU) are not clear." | 3.91 | Factors affecting the efficacy and safety of aminophylline in treatment of apnea of prematurity in neonatal intensive care unit. ( Dong, Z; Lu, X; Lyu, Q; Mao, Y; Miao, C; Ye, C; Yu, L; Zhang, J, 2019) |
"346), apnea (OR = 2." | 3.88 | Retinopathy of Prematurity Among Very Low-Birth-Weight Infants in China: Incidence and Perinatal Risk Factors. ( Mu, D; Qu, Y; Tong, Y; Wu, T; Xia, B; Zhang, L, 2018) |
" Sixty percent reported increasing frequency of apnea-bradycardia events following immunization." | 3.88 | Variability in Immunization Practices for Preterm Infants. ( Creech, B; Edwards, KM; Gopal, SH; Weitkamp, JH, 2018) |
"Incidence fell from 74% diagnosed with apnea of prematurity at baseline to 49% diagnosed with CSCPE postimplementation (P<0." | 3.85 | Clinically significant cardiopulmonary events and the effect of definition standardization on apnea of prematurity management. ( Ahlers-Schmidt, CR; Bloom, BT; Engel, M; Powell, MB, 2017) |
"We evaluated the following outcomes: 1) bloodstream infections, 2) culture-negative sepsis, 3) number of sepsis evaluations, and 4) number of significant apnea/bradycardia events comparing odds ratios between 72 hours before and 72 hours after peripherally inserted central venous catheter removal." | 3.80 | Incidence of catheter-related bloodstream infections in neonates following removal of peripherally inserted central venous catheters. ( Casner, M; Hill, M; Hoesli, SJ; Slaughter, JC; Weitkamp, JH, 2014) |
"Three hundred and thirty-eight DBS cards for caffeine measurement were collected from 67 preterm infants (birth weight 0." | 3.79 | Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants. ( Della Pasqua, O; Field, DJ; Gade, S; Kairamkonda, V; Mulla, H; Pandya, HC; Patel, P; Spooner, N, 2013) |
" Prematurity and perioperative sedation have been shown to be risk factors for postoperative apnea." | 3.78 | Predictive factors of PACU stay after herniorraphy in infant: a classification and regression tree analysis. ( Brasher, C; Dahmani, S; Julien, F; Mantz, J; Nivoche, Y; Silins, V, 2012) |
"This study evaluated the optimal timing for repair, incarceration risk, and postoperative apnea rate in premature infants with inguinal hernias." | 3.77 | A critical review of premature infants with inguinal hernias: optimal timing of repair, incarceration risk, and postoperative apnea. ( Gleason, JM; Lee, SL; Sydorak, RM, 2011) |
"Clinically relevant apneas, which are common in preterm infants, may adversely affect later neuropsychological condition in this group of patients." | 3.75 | Differential diagnosis of apneas in preterm infants. ( Dittrichová, J; Melichar, J; Miletín, J; Paul, K, 2009) |
"001), apnea (P=0." | 3.75 | Retinopathy of prematurity in a tertiary care center--incidence, risk factors and outcome. ( Chaudhari, S; Kadam, S; Kamat, A; Patwardhan, V; Vaidya, U, 2009) |
"Doxapram is a respiratory stimulant widely used for the treatment of idiopathic apnea of prematurity, although it has been demonstrated that it can induce a transient decrease of cerebral blood flow and that isolated mental delay in infants weighing <1,250 g is associated with the total dosage and duration of doxapram therapy." | 3.73 | Brain hemodynamic effects of doxapram in preterm infants. ( Bertini, G; Dani, C; Filippi, L; Pezzati, M; Pratesi, S; Rubaltelli, FF; Tronchin, M, 2006) |
"Adverse cardiorespiratory events including apnea, bradycardia, and desaturations have been described following administration of the first diphtheria-tetanus-pertussis-inactivated polio-Haemophilus influenzae type B (DTP-IPV-Hib) immunization to preterm infants." | 3.73 | Frequency of apnea, bradycardia, and desaturations following first diphtheria-tetanus-pertussis-inactivated polio-Haemophilus influenzae type B immunization in hospitalized preterm infants. ( Lee, J; Robinson, JL; Spady, DW, 2006) |
"Apnea of prematurity develop during the first days of life and usually resolve by the time the infant reaches 36-37 weeks postmenstrual age." | 3.73 | [Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate]. ( Baudon, JJ; Biran-Mucignat, V; Boelle, PY; Ducrocq, S; Gold, F; Lebas, F, 2006) |
"Premature infants need to attain both medical stability and maturational milestones (specifically, independent thermoregulation, resolution of apnea of prematurity, and the ability to feed by mouth) before safe discharge to home." | 3.71 | Inter-neonatal intensive care unit variation in discharge timing: influence of apnea and feeding management. ( Blackwell, M; Eichenwald, EC; Lloyd, JS; Richardson, DK; Tran, T; Wilker, RE, 2001) |
"To identify current factors associated with home apnea monitor use in preterm infants and to determine whether home monitor use was associated with a shorter length of hospital stay." | 3.71 | Home apnea monitor use in preterm infants discharged from newborn intensive care units. ( Clark, R; Dodd, E; Peabody, J; Perfect Sychowski, S; Thomas, P, 2001) |
"Apnea of prematurity is common and none of the treatments being used are fully effective and free of significant adverse side effects." | 3.71 | Inhalation of low (0.5%-1.5%) CO2 as a potential treatment for apnea of prematurity. ( Al-Aif, S; Alvaro, R; Cates, D; Kwiatkowski, K; Manfreda, J; Rigatto, H, 2001) |
" This study was designed to test the hypothesis that recurrent central apneas in preterm infants are correlated with a reduced prostacyclin to thromboxane A2 ratio." | 3.70 | Reduced prostacyclin to thromboxane A2 ratio is correlated with central apneas in preterm infants. ( Bernhard, M; Hoch, B, 1999) |
"9 seconds central respiratory pauses (RP), the apnea index (AI) [AI=% of nonbreathing time], and the time spent with periodic breathing (PB), as compared with AGA infants." | 3.69 | Respiratory characteristics during sleep in healthy small-for- gestational age newborns. ( Christova, E; Curzi-Dascalova, L; Peirano, P, 1996) |
" Under baseline conditions, prenatal cocaine 1) increased the number of apneas expressed by silence of EMGdi or EMGpca and prolonged the duration of EMGpca-related apneas at both ages; 2) increased the number of periodic breathing episodes at both ages; 3) increased percent time of active sleep and decreased that of wakefulness at both ages; and 4) increased time in quiet sleep in the older animals, producing in them a sleep-wake distribution similar to that of the young neonates." | 3.69 | Chronic prenatal cocaine retards maturation of state and of respiratory patterns in swine. ( Laferrière, A; Moss, IR, 1995) |
" Immaturity at delivery, metabolic acidosis, respiratory distress syndrome and recurrent apnea are important mechanisms of cerebral injury contributing to severity of PVH-IVH." | 3.68 | Neonatal complications and risk of intraventricular-periventricular hemorrhage. ( Ciarlini, G; Ferrari, B; Luzietti, R; Merialdi, A; Tonni, G; Vadora, E, 1992) |
"This research was an exploratory follow-up study of 51 infants who had experienced an "apparent life-threatening event" (ALTE) characterized by apnea and subsequent home cardiorespiratory monitoring." | 3.68 | Apparent life-threatening events during infancy: a follow-up study of subsequent growth and development. ( Baroni, MA, 1991) |
"The occurrence of central apnea of 15 seconds or longer, transient episodes of bradycardia (TEB), and periodic breathing were studied in 66 healthy premature infants when at least 1 week old and between 32 and 36 weeks postconceptual age." | 3.68 | Apnea, transient episodes of bradycardia, and periodic breathing in preterm infants. ( Cabal, LA; Gonzalez, F; Hodgman, JE; Hoppenbrouwers, T, 1990) |
"Recordings of breathing movements and heart rate (pneumograms) were obtained prospectively in 89 preterm infants at 0-28 days of age to determine if those who develop apnea and/or bradycardia with cyanosis (Group 1) differ from those who do not (Group 2)." | 3.68 | Prospective pneumogram recordings in preterm infants with and without clinical apnea and bradycardia. ( Kelly, DH; McCulloch, KM, 1990) |
"Twelve premature infants with significant apnea of prematurity while receiving therapeutic doses of aminophylline were given an intravenous infusion of doxapram, 2 or 2." | 3.67 | Physiologic effects of doxapram in idiopathic apnea of prematurity. ( Barrington, KJ; Barton, J; Finer, NN; Peters, KL, 1986) |
"Apnea, bradycardia, and neuromuscular hyperirritability have been associated with magnesium (Mg) deficiency in young human infants and weanling animals." | 3.67 | Magnesium therapy in premature neonates with apnea neonatorum. ( Caddell, JL, 1988) |
"To determine the relationship of electrocardiographic changes to both intraventricular hemorrhage (IVH) and neonatal apnea, continuous electrocardiographic monitoring, serial electrocardiograms, and cranial echoencephalograms were obtained on 41 consecutive preterm neonates with birth weight below 1,250 g." | 3.67 | The electrocardiogram in preterm infants with intraventricular hemorrhage and apnea. ( Colavita, RD; Ment, LR, 1986) |
"To evaluate the relationship of antecedent maternal smoking and caffeine consumption habits on the occurrence of apnea in their offspring, rates for central and obstructive apnea were analyzed in a cohort of mother-infant pairs." | 3.67 | Effects of maternal smoking and caffeine habits on infantile apnea: a retrospective study. ( Bendell, D; Duke, JC; Mattice, CD; McCaffree, MA; Orr, WC; Toubas, PL, 1986) |
" Twelve infants were premature with a history of apnea, eight were premature without known apnea, and 10 were born at term." | 3.67 | Risk of hypoventilation in premature infants in car seats. ( Leuschen, MP; Nelson, LS; Nelson, RM; Willett, LD, 1986) |
"001); apnea requiring bag and mask resuscitation with oxygen (P less than ." | 3.66 | Risk factors in retrolental fibroplasia. ( Aranda, JV; Easdown, J; Gunn, TR; Outerbridge, EW, 1980) |
"The efficacy of theophylline in preventing severe apnea was evaluated in 17 low-birthweight infants (mean weight, 1,400 gm)." | 3.65 | Prevention of apnea and bradycardia in low-birthweight infants. ( Gotay, F; Moylan, FM; Rogers, MC; Shannon, DC; Stein, IM; Todres, ID, 1975) |
" No over-all pattern relating sleep state to frequency of apnea could be detected for individual infants." | 3.65 | Sleep state, apnea and bradycardia in pre-term infants. ( Auld, PA; Krauss, AN; Solomon, GE, 1977) |
" irregular breathing leading to recurrent apnea and bradycardia in an otherwise healthy preterm infant, has been studied in respect of symptomathology and management with intensive case including ventilatory support." | 3.65 | Respiratory insufficiency syndrome (RIS) in preterm infants with gestational age of 32 weeks and less. Neonatal management and follow-up study. ( Carlsson, J; Svenningsen, NW, 1975) |
"To identify dosing strategies that will assure stable caffeine concentrations in preterm neonates despite changing caffeine clearance during the first 8 weeks of life." | 1.46 | Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates. ( Datta, AN; Jost, K; Koch, G; Pfister, M; Schulzke, SM; van den Anker, J, 2017) |
"Mean birth weight was lower in the apnoea group versus the breathing group (683 vs." | 1.46 | Effects of Breathing and Apnoea during Sustained Inflations in Resuscitation of Preterm Infants. ( Bresesti, I; Castoldi, F; Cavigioli, F; La Verde, PA; Lista, G; Morley, CJ, 2017) |
"Retinopathy of prematurity was detected in 10." | 1.35 | Risk factors for retinopathy of prematurity in six neonatal intensive care units in Beijing, China. ( Chen, Y; Gilbert, C; Jiang, YR; Li, XX; Liang, JH; Yin, H; Zhao, MW, 2008) |
"Brain abscess and hypoxemia were thought to be serious complications resulting from CAPV and were successfully corrected by living donor liver transplantation at the age of 4 months." | 1.33 | Successful liver transplantation for congenital absence of the portal vein complicated by intrapulmonary shunt and brain abscess. ( Doi, H; Haga, H; Kamei, H; Kasahara, M; Ogawa, K; Ogura, Y; Ohnishi, Y; Tanaka, K; Ueda, M; Yoshitoshi, EY, 2005) |
"Vomiting was present in 4% of the newborns, gastric aspirates in 22% and apnoeas in 41% after the examination." | 1.32 | Screening for retinopathy of prematurity: is it painful? ( Belda, S; De la Cruz, J; Pallás, CR; Tejada, P, 2004) |
"The incidence of sudden infant death syndrome (SIDS) has been found to be consistently higher in preterm and low birth weight infants than in infants born at term and this increase is inversely related to gestational age." | 1.31 | Apnoea of prematurity and arousal from sleep. ( Adamson, TM; Andrew, S; Chau, B; Cranage, SM; Horne, RS; Mitchell, K; Sly, DJ, 2001) |
"The overall incidence of SIDS exceeded that of PIA by a factor of 3." | 1.27 | Epidemiological comparisons of sudden infant death syndrome with infant apnoea. ( Bossung-Sweeney, L; Davis, N; Peterson, DR, 1986) |
"16% from Apnoe and approx." | 1.25 | [Infants of low birth weight after deliveries, morbidity and mortality (author's transl)]. ( Hohlweg-Majert, P; Kauert, S, 1975) |
"Within a three-month period 13 cases of listeriosis in the newborn were seen at the National Women's Hospital, Auckland." | 1.25 | Epidemic listeriosis in the newborn. ( Becroft, DM; Farmer, K; Seddon, RJ; Sowden, R; Stewart, JH; Vines, A; Wattie, DA, 1971) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 83 (54.25) | 18.7374 |
1990's | 19 (12.42) | 18.2507 |
2000's | 22 (14.38) | 29.6817 |
2010's | 25 (16.34) | 24.3611 |
2020's | 4 (2.61) | 2.80 |
Authors | Studies |
---|---|
Yee, AK | 1 |
Siriwardhana, LS | 1 |
Nixson, GM | 1 |
Walter, LM | 1 |
Wong, FY | 1 |
Horne, RSC | 1 |
Moresco, L | 1 |
Sjögren, A | 1 |
Marques, KA | 1 |
Soll, R | 1 |
Bruschettini, M | 1 |
Shirwaikar, RD | 1 |
Acharya U, D | 1 |
Makkithaya, K | 1 |
M, S | 1 |
Srivastava, S | 1 |
Lewis U, LES | 1 |
Sullivan, BA | 1 |
Slevin, CC | 1 |
Ahmad, SM | 1 |
Sinkin, RA | 1 |
Fairchild, KD | 1 |
Schmidt, B | 1 |
Roberts, RS | 1 |
Anderson, PJ | 1 |
Asztalos, EV | 1 |
Costantini, L | 1 |
Davis, PG | 2 |
Dewey, D | 1 |
D'Ilario, J | 1 |
Doyle, LW | 1 |
Grunau, RE | 1 |
Moddemann, D | 1 |
Nelson, H | 1 |
Ohlsson, A | 1 |
Solimano, A | 1 |
Tin, W | 1 |
Ahmed, F | 1 |
Mannan, MA | 1 |
Dey, AC | 1 |
Nahar, N | 1 |
Hasan, Z | 1 |
Jahan, I | 1 |
Dey, SK | 1 |
Shahidullah, M | 1 |
Koch, G | 1 |
Datta, AN | 1 |
Jost, K | 1 |
Schulzke, SM | 1 |
van den Anker, J | 1 |
Pfister, M | 1 |
Wu, T | 1 |
Zhang, L | 1 |
Tong, Y | 1 |
Qu, Y | 1 |
Xia, B | 1 |
Mu, D | 1 |
Ye, C | 1 |
Miao, C | 1 |
Yu, L | 1 |
Dong, Z | 1 |
Zhang, J | 1 |
Mao, Y | 1 |
Lu, X | 1 |
Lyu, Q | 1 |
Gopal, SH | 1 |
Edwards, KM | 1 |
Creech, B | 1 |
Weitkamp, JH | 2 |
Oishi, Y | 1 |
Ohta, H | 1 |
Hirose, T | 1 |
Nakaya, S | 1 |
Tsuchiya, K | 1 |
Nakagawa, M | 1 |
Kusakawa, I | 1 |
Sato, T | 1 |
Obonai, T | 1 |
Nishida, H | 1 |
Yoda, H | 1 |
de Waal, CG | 1 |
Hutten, GJ | 1 |
Kraaijenga, JV | 1 |
de Jongh, FH | 1 |
van Kaam, AH | 1 |
Kou, C | 1 |
Han, D | 1 |
Li, Z | 1 |
Wu, W | 1 |
Liu, Z | 1 |
Zhang, Y | 1 |
Gao, Z | 1 |
Casner, M | 1 |
Hoesli, SJ | 1 |
Slaughter, JC | 1 |
Hill, M | 1 |
Shin, SH | 1 |
Kim, HS | 1 |
Lee, J | 2 |
Choi, KY | 1 |
Lee, JH | 1 |
Kim, EK | 1 |
Park, MS | 1 |
Choi, JH | 1 |
Tong, X | 1 |
Xue, X | 1 |
Fu, J | 1 |
Kreutzer, K | 1 |
Bassler, D | 1 |
Silveira, CS | 1 |
Leonardi, KM | 1 |
Melo, AP | 1 |
Zaia, JE | 1 |
Brunherotti, MA | 1 |
Zhao, Y | 1 |
Tian, X | 1 |
Liu, G | 1 |
Budhathoki, S | 1 |
Poudel, P | 1 |
Bhatta, NK | 1 |
Singh, RR | 1 |
Shrivastava, MK | 1 |
Niraula, SR | 1 |
Khanal, B | 1 |
Kesavan, K | 1 |
Frank, P | 1 |
Cordero, DM | 1 |
Benharash, P | 1 |
Harper, RM | 1 |
Reid, B | 1 |
Wang, H | 1 |
Guillet, R | 1 |
Powell, MB | 1 |
Ahlers-Schmidt, CR | 1 |
Engel, M | 1 |
Bloom, BT | 1 |
Lista, G | 1 |
Cavigioli, F | 1 |
La Verde, PA | 1 |
Castoldi, F | 1 |
Bresesti, I | 1 |
Morley, CJ | 2 |
Paul, K | 1 |
Melichar, J | 1 |
Miletín, J | 1 |
Dittrichová, J | 1 |
Shah, PS | 2 |
Perlman, M | 1 |
Pantalitschka, T | 1 |
Sievers, J | 1 |
Urschitz, MS | 1 |
Herberts, T | 1 |
Reher, C | 1 |
Poets, CF | 2 |
Chaudhari, S | 1 |
Patwardhan, V | 1 |
Vaidya, U | 1 |
Kadam, S | 1 |
Kamat, A | 1 |
Nishiura, H | 1 |
Kimura, A | 1 |
Yamato, Y | 1 |
Aoki, K | 1 |
Inokuchi, T | 1 |
Kurosawa, T | 1 |
Matsuishi, T | 1 |
Lee, SL | 1 |
Gleason, JM | 1 |
Sydorak, RM | 1 |
Owen, LS | 1 |
Dawson, JA | 1 |
Silins, V | 1 |
Julien, F | 1 |
Brasher, C | 1 |
Nivoche, Y | 1 |
Mantz, J | 1 |
Dahmani, S | 1 |
Patel, P | 1 |
Mulla, H | 1 |
Kairamkonda, V | 1 |
Spooner, N | 1 |
Gade, S | 1 |
Della Pasqua, O | 1 |
Field, DJ | 1 |
Pandya, HC | 1 |
Stefanescu, BM | 1 |
Murphy, WP | 1 |
Hansell, BJ | 1 |
Fuloria, M | 1 |
Morgan, TM | 1 |
Aschner, JL | 1 |
Wu, XJ | 1 |
Xu, YP | 1 |
Shi, LP | 1 |
Kim, TI | 1 |
Sohn, J | 1 |
Pi, SY | 1 |
Yoon, YH | 1 |
Belda, S | 1 |
Pallás, CR | 1 |
De la Cruz, J | 1 |
Tejada, P | 1 |
Ohnishi, Y | 1 |
Ueda, M | 1 |
Doi, H | 1 |
Kasahara, M | 1 |
Haga, H | 1 |
Kamei, H | 1 |
Ogawa, K | 1 |
Ogura, Y | 1 |
Yoshitoshi, EY | 1 |
Tanaka, K | 1 |
Dani, C | 2 |
Bertini, G | 2 |
Pezzati, M | 1 |
Pratesi, S | 1 |
Filippi, L | 1 |
Tronchin, M | 2 |
Rubaltelli, FF | 2 |
Sale, SM | 1 |
Read, JA | 1 |
Stoddart, PA | 1 |
Wolf, AR | 1 |
Robinson, JL | 1 |
Spady, DW | 1 |
Campbell, DM | 1 |
Shah, V | 1 |
Kelly, EN | 1 |
Ducrocq, S | 1 |
Biran-Mucignat, V | 1 |
Boelle, PY | 1 |
Lebas, F | 1 |
Baudon, JJ | 1 |
Gold, F | 1 |
Chen, Y | 1 |
Li, XX | 1 |
Yin, H | 1 |
Gilbert, C | 1 |
Liang, JH | 1 |
Jiang, YR | 1 |
Zhao, MW | 1 |
Carbone, T | 1 |
McEntire, B | 1 |
Kissin, D | 1 |
Kelly, D | 1 |
Steinschneider, A | 1 |
Violaris, K | 1 |
Karamchandani, N | 1 |
Creery, RD | 1 |
Waugh, R | 1 |
Johnson, GG | 1 |
Thompson, RG | 1 |
Finer, NN | 2 |
Peters, KL | 2 |
Duffley, LM | 1 |
Coward, JH | 1 |
Flynn, JT | 1 |
Gunn, TR | 2 |
Easdown, J | 1 |
Outerbridge, EW | 1 |
Aranda, JV | 1 |
Lagercrantz, H | 1 |
Sjöquist, B | 1 |
Rossiter, EJ | 1 |
Moss, IR | 1 |
Laferrière, A | 1 |
Coté, CJ | 1 |
Zaslavsky, A | 1 |
Downes, JJ | 1 |
Kurth, CD | 1 |
Welborn, LG | 1 |
Warner, LO | 1 |
Malviya, SV | 1 |
Svenningsen, NW | 2 |
Wittström, C | 1 |
Hellström-Westas, L | 1 |
Curzi-Dascalova, L | 1 |
Peirano, P | 1 |
Christova, E | 1 |
Claris, O | 1 |
Salle, BL | 1 |
Lapillonne, A | 1 |
Ronin, E | 1 |
Picaud, JC | 1 |
Besnier, S | 1 |
Rehan, VK | 1 |
Fajardo, CA | 1 |
Haider, AZ | 1 |
Alvaro, RE | 1 |
Cates, DB | 1 |
Kwiatkowski, K | 2 |
Nowaczyk, B | 1 |
Rigatto, H | 4 |
al-Omran, A | 1 |
al-Alaiyan, S | 1 |
Botham, SJ | 1 |
Isaacs, D | 1 |
Henderson-Smart, DJ | 1 |
da Silva, O | 1 |
Stevens, D | 1 |
Darraj, S | 1 |
Bohnhorst, B | 1 |
Hoch, B | 1 |
Bernhard, M | 1 |
Tonkin, SL | 1 |
Hadden, W | 1 |
Davis, SL | 1 |
Gunn, AJ | 1 |
Reali, MF | 1 |
Wiechmann, L | 1 |
Martelli, E | 1 |
Horne, RS | 1 |
Andrew, S | 1 |
Mitchell, K | 1 |
Sly, DJ | 1 |
Cranage, SM | 1 |
Chau, B | 1 |
Adamson, TM | 1 |
Al-Aif, S | 1 |
Alvaro, R | 1 |
Manfreda, J | 1 |
Cates, D | 1 |
Perfect Sychowski, S | 1 |
Dodd, E | 1 |
Thomas, P | 1 |
Peabody, J | 1 |
Clark, R | 1 |
Eichenwald, EC | 1 |
Blackwell, M | 1 |
Lloyd, JS | 1 |
Tran, T | 1 |
Wilker, RE | 1 |
Richardson, DK | 1 |
Speidel, BD | 2 |
Dunn, PM | 2 |
Krauss, AN | 2 |
Solomon, GE | 1 |
Auld, PA | 2 |
Shannon, DC | 1 |
Gotay, F | 1 |
Stein, IM | 1 |
Rogers, MC | 1 |
Todres, ID | 1 |
Moylan, FM | 1 |
Jones, MD | 1 |
Murton, LJ | 1 |
Valdes-Dapena, M | 1 |
Kendeel, SR | 1 |
Ferris, JA | 1 |
Friis-Hansen, B | 2 |
Lou, HC | 1 |
Marstrand-Christiansen, P | 1 |
Scheibel, E | 1 |
McDiarmid, JM | 1 |
Silva, PA | 1 |
Eisenberg, W | 1 |
Holzgraefe, E | 1 |
Naim, M | 1 |
Fitzhardinge, PM | 2 |
Pape, P | 1 |
Arstikaitis, M | 1 |
Boyle, M | 1 |
Ashby, S | 1 |
Rowley, A | 1 |
Netley, C | 1 |
Swyer, PR | 3 |
Assael, BM | 1 |
Caccamo, ML | 1 |
Gerna, M | 1 |
Latini, R | 1 |
Mandelli, M | 1 |
Marini, A | 1 |
Sereni, F | 1 |
Tognoni, G | 1 |
Fich, CF | 1 |
Frederiksen, PS | 1 |
Kamper, J | 1 |
Hodr, R | 1 |
Nikl, J | 1 |
Pawlowski, P | 1 |
Venzmer, J | 1 |
Wiedersberg, H | 1 |
Kattwinkel, J | 1 |
Nearman, HS | 1 |
Fanaroff, AA | 1 |
Katona, PG | 1 |
Klaus, MH | 1 |
Coran, AG | 1 |
Cabal, L | 1 |
Siassi, B | 1 |
Rosenkrantz, JG | 1 |
Hasselmeyer, EG | 1 |
Hunter, JC | 1 |
Carlsson, J | 1 |
Roberton, NR | 1 |
Smith, MA | 1 |
Hohlweg-Majert, P | 1 |
Kauert, S | 1 |
Ferrari, B | 1 |
Tonni, G | 1 |
Luzietti, R | 1 |
Ciarlini, G | 1 |
Vadora, E | 1 |
Merialdi, A | 1 |
Merchant, RH | 1 |
Sakhalkar, VS | 1 |
Ashavaid, TF | 1 |
Palme-Kilander, C | 1 |
Baroni, MA | 1 |
Tashiro, C | 1 |
Matsui, Y | 1 |
Nakano, S | 1 |
Ueyama, H | 1 |
Nishimura, M | 1 |
Oka, N | 1 |
Hodgman, JE | 1 |
Gonzalez, F | 1 |
Hoppenbrouwers, T | 1 |
Cabal, LA | 1 |
McCulloch, KM | 1 |
Kelly, DH | 1 |
Kishan, J | 1 |
Valdez, ME | 1 |
Mir, NA | 1 |
Elzouki, AY | 1 |
Purohit, DM | 1 |
Ellison, RC | 1 |
Zierler, S | 1 |
Miettinen, OS | 1 |
Nadas, AS | 1 |
Hoffman, HJ | 1 |
Damus, K | 1 |
Hillman, L | 1 |
Krongrad, E | 1 |
Barrington, KJ | 1 |
Barton, J | 1 |
Durand, DJ | 1 |
Goodman, A | 1 |
Ray, P | 1 |
Ballard, RA | 1 |
Clyman, RI | 1 |
Caddell, JL | 1 |
Saigal, S | 1 |
Watts, J | 1 |
Campbell, D | 1 |
Okoro, BA | 1 |
Okeahialam, TC | 1 |
Colavita, RD | 1 |
Ment, LR | 1 |
Toubas, PL | 1 |
Duke, JC | 1 |
McCaffree, MA | 1 |
Mattice, CD | 1 |
Bendell, D | 1 |
Orr, WC | 1 |
Willett, LD | 1 |
Leuschen, MP | 1 |
Nelson, LS | 1 |
Nelson, RM | 1 |
Davis, JM | 1 |
Abbasi, S | 1 |
Spitzer, AR | 1 |
Johnson, L | 1 |
Davis, N | 1 |
Bossung-Sweeney, L | 1 |
Peterson, DR | 1 |
Keenan, WJ | 1 |
Novak, KK | 1 |
Sutherland, JM | 2 |
Bryla, DA | 1 |
Fetterly, KL | 1 |
Wilkinson, A | 1 |
Yu, VY | 1 |
Reid, DH | 1 |
Higgs, SC | 1 |
Malan, AF | 1 |
De Heese, HV | 1 |
Steele, RW | 1 |
Copeland, GA | 1 |
Fenner, A | 1 |
Schalk, U | 1 |
Hoenicke, H | 1 |
Wendenburg, A | 1 |
Roehling, T | 1 |
Beckwith, JB | 1 |
Stewart, AL | 1 |
Reynolds, EO | 2 |
Francis-Williams, J | 1 |
Davies, PA | 1 |
Rosegger, H | 1 |
Buckfield, PM | 1 |
Alden, ER | 2 |
Mandelkorn, T | 1 |
Woodrum, DE | 1 |
Wennberg, RP | 1 |
Parks, CR | 1 |
Hodson, WA | 2 |
Riegel, K | 1 |
Welsch, H | 1 |
Tori, CA | 1 |
Brown, J | 1 |
Soodalter, J | 1 |
Gupta, JM | 3 |
Van Vliet, PK | 3 |
Vonwiller, JB | 1 |
Abrahams, N | 1 |
Fisk, GC | 2 |
Wealthall, SR | 1 |
Whittaker, GE | 1 |
Greenwood, N | 1 |
Bryan, MH | 1 |
Wei, P | 1 |
Hamilton, JR | 1 |
Chance, GW | 1 |
Gershanik, JJ | 1 |
Levkoff, AH | 1 |
Duncan, R | 1 |
Ramsay, M | 1 |
Kalina, RE | 1 |
De Souza, SW | 1 |
Davis, JA | 1 |
Picton-Warlow, CG | 1 |
Brady, JP | 2 |
Becroft, DM | 1 |
Farmer, K | 1 |
Seddon, RJ | 1 |
Sowden, R | 1 |
Stewart, JH | 1 |
Vines, A | 1 |
Wattie, DA | 1 |
Robinson, R | 1 |
Palm, DG | 1 |
Althoff, W | 1 |
Brüster, H | 1 |
Wirtz, P | 1 |
Perlstein, PH | 1 |
Edwards, NK | 1 |
Strang, LB | 1 |
Griffiths, AD | 1 |
Bretscher, J | 1 |
Daily, WJ | 1 |
Klaus, M | 1 |
Meyer, HB | 1 |
Morgan, J | 1 |
Stevens, LH | 1 |
Cope, TI | 1 |
Bacola, E | 1 |
Behrle, FC | 1 |
De Schweinitz, L | 1 |
Miller, HC | 1 |
Mira, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Efficacy and Safety of Methylxanthines in Very Low Birthweight Infants[NCT00182312] | Phase 3 | 2,000 participants (Anticipated) | Interventional | 1999-10-31 | Completed | ||
Pharmacokinetics (PK) and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia[NCT05295784] | Phase 1 | 18 participants (Anticipated) | Interventional | 2024-06-30 | Not yet recruiting | ||
High Versus Low Dose Caffeine as Respiratory Stimulant in Preterm Infants[NCT04144712] | Phase 1 | 80 participants (Anticipated) | Interventional | 2019-04-01 | Recruiting | ||
WAVE Trial in Premature Infants With Apnea of Prematurity Using a Simple, Non-invasive Vibratory Device to Study the Effectiveness in Supporting Breathing and General Stability[NCT04528030] | 17 participants (Anticipated) | Interventional | 2021-04-01 | Not yet recruiting | |||
Neuromodulation of Limb Proprioceptive Afferents Using a Vibratory Device to Decrease Apnea, Intermittent Hypoxia and Bradycardia of Prematurity.[NCT02641249] | 19 participants (Actual) | Interventional | 2014-10-31 | Completed | |||
Integrated Prediction of Extubation Outcome by the Spontaneous Breathing Trial in Newborn Infants[NCT03956511] | 46 participants (Actual) | Observational | 2016-02-29 | Completed | |||
Utility of Spontaneous Breathing Trial (SBT) Using ET-CPAP, in Predicting Extubation Failure in Neonates[NCT03091387] | 110 participants (Anticipated) | Observational | 2017-04-30 | Not yet recruiting | |||
Efficiency and Safety of Phenylephrine and Tropicamide Used in Premature Retinopathy[NCT03448640] | 60 participants (Actual) | Observational | 2016-01-15 | Completed | |||
Comparison of Humidified High Flow Nasal Cannula to Nasal Continuous Positive Airway Pressure for Non-Invasive Respiratory Support in Neonates[NCT00609882] | 420 participants (Actual) | Interventional | 2007-12-31 | Completed | |||
Adaptive Dynamic Inspiratory Nasal Apparatus (ADINA): Comparison to High Flow Nasal Cannula (HFNC)[NCT03171129] | 40 participants (Anticipated) | Interventional | 2024-01-31 | Not yet recruiting | |||
Prolonged Apnea and Prolonged Bradycardia Following DTaP Immunization in Preterm Infants: A Randomized Multicenter Study[NCT00482781] | 191 participants (Actual) | Interventional | 2000-09-30 | Completed | |||
A Prospective, Controlled Trial of Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea of Prematurity[NCT01911182] | Phase 2/Phase 3 | 7 participants (Actual) | Interventional | 2011-10-31 | Terminated (stopped due to Low recruitment rate) | ||
[NCT01066728] | Phase 2/Phase 3 | 87 participants (Actual) | Interventional | 2001-08-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
The total number of bradycardia episodes to <100 bpm lasting >5 seconds/episode will be compared during periods of vibration (intervention) to periods of no vibrations (no intervention). (NCT02641249)
Timeframe: 12 hours of intervention/12 hours of no intervention
Intervention | bradycardias (Mean) |
---|---|
No Vibration | 50.53 |
Vibration | 14.93 |
The total number of intermittent hypoxic episodes to <90% (pulse oximetry) lasting >5 seconds/episode will be compared during periods of vibration (intervention) to periods of no vibrations (no intervention). (NCT02641249)
Timeframe: 12 hours of intervention/12 hours of no intervention
Intervention | IH events (Mean) |
---|---|
No Vibration | 151.67 |
Vibration | 109.67 |
The total number of apneas/breathing pauses will be compared during periods of vibration (intervention) to periods of no vibrations (no intervention). (NCT02641249)
Timeframe: 12 hours of intervention/12 hours of no intervention
Intervention | breathing pauses (Mean) |
---|---|
No Vibration | 284.13 |
Vibration | 174.27 |
11 reviews available for apnea and Birth Weight
Article | Year |
---|---|
Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants.
Topics: Aminophylline; Apnea; Birth Weight; Bronchopulmonary Dysplasia; Caffeine; Hearing Loss; Humans; Infa | 2023 |
Caffeine for apnea of prematurity: a neonatal success story.
Topics: Animals; Apnea; Birth Weight; Caffeine; Cost-Benefit Analysis; Drug Costs; Gestational Age; Humans; | 2014 |
Hyperventilation, hypokalemia, and SIDS.
Topics: Apnea; Birth Weight; Carbon Dioxide; Chemoreceptor Cells; Depression; Diaphragm; Dietary Carbohydrat | 1984 |
The Geelong study.
Topics: Apnea; Birth Weight; Child; Child Behavior Disorders; Child, Preschool; Delivery, Obstetric; Develop | 1993 |
Mechanical ventilation in newborn infants with hyaline membrane disease;.
Topics: Acidosis; Apnea; Birth Weight; Bradycardia; Cerebral Hemorrhage; Ductus Arteriosus, Patent; Gestatio | 1977 |
Sudden unexplained infant death, 1970 through 1975 an evolution in understanding.
Topics: Age Factors; Antibodies; Apnea; Birth Order; Birth Weight; Environment; Female; Humans; Illegitimacy | 1977 |
Sudden infant death syndrome: a review of literature.
Topics: Agammaglobulinemia; Animals; Apnea; Asphyxia; Birth Weight; Food Hypersensitivity; Humans; Infant; I | 1977 |
The sudden infant death syndrome.
Topics: Age Factors; Antibody Formation; Apnea; Asphyxia; Autonomic Nervous System; Birth Weight; Female; Ge | 1975 |
Risk factors for SIDS. Results of the National Institute of Child Health and Human Development SIDS Cooperative Epidemiological Study.
Topics: Apnea; Birth Weight; Diarrhea, Infantile; Female; Humans; Infant; Infant, Newborn; Jaundice, Neonata | 1988 |
The sudden infant death syndrome.
Topics: Age Factors; Anaphylaxis; Apnea; Asphyxia; Autopsy; Birth Weight; Counseling; Death, Sudden; Feeding | 1973 |
[Urgent care for the high-risk newborn infant].
Topics: Apgar Score; Apnea; Birth Weight; Blood Transfusion; Edema; Erythroblastosis, Fetal; Female; Humans; | 1973 |
23 trials available for apnea and Birth Weight
Article | Year |
---|---|
Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Child Behavior Disorders; Child De | 2017 |
Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Child Behavior Disorders; Child De | 2017 |
Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Child Behavior Disorders; Child De | 2017 |
Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Child Behavior Disorders; Child De | 2017 |
Randomized Controlled Trial of Slow Versus Rapid Enteral Feeding Advancements on the Clinical Outcomes in Very Low Birth Weight Neonates.
Topics: Apnea; Birth Weight; Enteral Nutrition; Food Intolerance; Humans; Infant; Infant, Newborn; Infant, V | 2017 |
Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
Topics: Apnea; Birth Weight; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Citrat | 2020 |
A comparative study of two remifentanil doses for procedural pain in ventilated preterm infants: a randomized, controlled study*.
Topics: Analgesics, Opioid; Apnea; Birth Weight; Bradycardia; Catheterization, Central Venous; Double-Blind | 2014 |
Response of Preterm Infants to 2 Noninvasive Ventilatory Support Systems: Nasal CPAP and Nasal Intermittent Positive-Pressure Ventilation.
Topics: Apnea; Birth Weight; Continuous Positive Airway Pressure; Disease Progression; Epistaxis; Female; Ge | 2015 |
[Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
Topics: Apnea; Birth Weight; Caffeine; Citrates; Female; Gestational Age; Humans; Infant, Newborn; Infant, P | 2016 |
Neuromodulation of Limb Proprioceptive Afferents Decreases Apnea of Prematurity and Accompanying Intermittent Hypoxia and Bradycardia.
Topics: Afferent Pathways; Apnea; Birth Weight; Bradycardia; Extremities; Female; Gestational Age; Humans; H | 2016 |
Neuromodulation of Limb Proprioceptive Afferents Decreases Apnea of Prematurity and Accompanying Intermittent Hypoxia and Bradycardia.
Topics: Afferent Pathways; Apnea; Birth Weight; Bradycardia; Extremities; Female; Gestational Age; Humans; H | 2016 |
Neuromodulation of Limb Proprioceptive Afferents Decreases Apnea of Prematurity and Accompanying Intermittent Hypoxia and Bradycardia.
Topics: Afferent Pathways; Apnea; Birth Weight; Bradycardia; Extremities; Female; Gestational Age; Humans; H | 2016 |
Neuromodulation of Limb Proprioceptive Afferents Decreases Apnea of Prematurity and Accompanying Intermittent Hypoxia and Bradycardia.
Topics: Afferent Pathways; Apnea; Birth Weight; Bradycardia; Extremities; Female; Gestational Age; Humans; H | 2016 |
Randomised crossover trial of four nasal respiratory support systems for apnoea of prematurity in very low birthweight infants.
Topics: Apnea; Birth Weight; Continuous Positive Airway Pressure; Cross-Over Studies; Female; Gestational Ag | 2009 |
A randomized, controlled trial comparing two different continuous positive airway pressure systems for the successful extubation of extremely low birth weight infants.
Topics: Apnea; Birth Weight; Bradycardia; Cohort Studies; Female; Humans; Incidence; Infant, Newborn; Infant | 2003 |
A randomized, controlled trial comparing two different continuous positive airway pressure systems for the successful extubation of extremely low birth weight infants.
Topics: Apnea; Birth Weight; Bradycardia; Cohort Studies; Female; Humans; Incidence; Infant, Newborn; Infant | 2003 |
A randomized, controlled trial comparing two different continuous positive airway pressure systems for the successful extubation of extremely low birth weight infants.
Topics: Apnea; Birth Weight; Bradycardia; Cohort Studies; Female; Humans; Incidence; Infant, Newborn; Infant | 2003 |
A randomized, controlled trial comparing two different continuous positive airway pressure systems for the successful extubation of extremely low birth weight infants.
Topics: Apnea; Birth Weight; Bradycardia; Cohort Studies; Female; Humans; Incidence; Infant, Newborn; Infant | 2003 |
Prospective comparison of sevoflurane and desflurane in formerly premature infants undergoing inguinal herniotomy.
Topics: Anesthesia Recovery Period; Anesthetics, Inhalation; Apnea; Birth Weight; Desflurane; Gestational Ag | 2006 |
Nasal continuous positive airway pressure from high flow cannula versus Infant Flow for Preterm infants.
Topics: Apnea; Birth Weight; Catheterization; Female; Gestational Age; Humans; Infant, Newborn; Infant, Prem | 2006 |
Nasal continuous positive airway pressure from high flow cannula versus Infant Flow for Preterm infants.
Topics: Apnea; Birth Weight; Catheterization; Female; Gestational Age; Humans; Infant, Newborn; Infant, Prem | 2006 |
Nasal continuous positive airway pressure from high flow cannula versus Infant Flow for Preterm infants.
Topics: Apnea; Birth Weight; Catheterization; Female; Gestational Age; Humans; Infant, Newborn; Infant, Prem | 2006 |
Nasal continuous positive airway pressure from high flow cannula versus Infant Flow for Preterm infants.
Topics: Apnea; Birth Weight; Catheterization; Female; Gestational Age; Humans; Infant, Newborn; Infant, Prem | 2006 |
Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study.
Topics: Apnea; Birth Weight; Bradycardia; Diphtheria-Tetanus-acellular Pertussis Vaccines; Double-Blind Meth | 2008 |
An evaluation of theophylline for idiopathic apnea of infancy.
Topics: Apnea; Birth Weight; Clinical Trials as Topic; Humans; Infant; Infant, Newborn; Infant, Premature, D | 1984 |
Postoperative apnea in former preterm infants after inguinal herniorrhaphy. A combined analysis.
Topics: Aging; Analysis of Variance; Anemia; Anesthesia; Apnea; Birth Weight; Hernia, Inguinal; Humans; Infa | 1995 |
Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants.
Topics: Apnea; Birth Weight; Bradycardia; Caffeine; Doxapram; Drug Resistance; Gestational Age; Humans; Hypo | 1999 |
Brain hemodynamic changes in preterm infants after maintenance dose caffeine and aminophylline treatment.
Topics: Aminophylline; Apnea; Birth Weight; Blood Flow Velocity; Blood Volume; Caffeine; Central Nervous Sys | 2000 |
Apnea of prematurity. Comparative therapeutic effects of cutaneous stimulation and nasal continuous positive airway pressure.
Topics: Apnea; Birth Weight; Cyanosis; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases | 1975 |
Prophylactic theophylline infusion for prevention of apnea of prematurity.
Topics: Aminophylline; Apnea; Birth Weight; Humans; Infant, Newborn; Infant, Premature, Diseases; Infusions, | 1992 |
Theophylline treatment in the extubation of infants weighing less than 1,250 grams: a controlled trial.
Topics: Apnea; Birth Weight; Body Weight; Clinical Trials as Topic; Humans; Infant, Low Birth Weight; Infant | 1987 |
Randomized clinical trial of an oscillating air mattress in preterm infants: effect on apnea, growth, and development.
Topics: Air; Apnea; Beds; Birth Weight; Body Weight; Bradycardia; Child Behavior; Child Development; Clinica | 1986 |
A comparison of oral feeding and total parenteral nutrition in infants of very low birthweight.
Topics: Amino Acids; Apnea; Birth Weight; Cholesterol; Clinical Trials as Topic; Enteral Nutrition; Female; | 1974 |
Oxygen chemoreceptors in low birth weight infants.
Topics: Age Factors; Altitude; Apnea; Atmospheric Pressure; Birth Weight; Chemoreceptor Cells; Clinical Tria | 1973 |
Supplemental intravenous alimentation in low-birth-weight infants.
Topics: Amino Acids; Apnea; Birth Weight; Blood Glucose; Body Weight; Chromatography, Thin Layer; Fibrin; Ge | 1973 |
119 other studies available for apnea and Birth Weight
Article | Year |
---|---|
Developmental consequences of short apneas and periodic breathing in preterm infants.
Topics: Apnea; Birth Weight; Child; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Inf | 2023 |
Optimizing neural networks for medical data sets: A case study on neonatal apnea prediction.
Topics: Algorithms; Apnea; Birth Weight; Clinical Decision Rules; Datasets as Topic; Decision Trees; Deep Le | 2019 |
Achievement of maturational milestones among very low birth weight infants.
Topics: Apnea; Birth Weight; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low | 2022 |
Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationsh | 2017 |
Retinopathy of Prematurity Among Very Low-Birth-Weight Infants in China: Incidence and Perinatal Risk Factors.
Topics: Apnea; Birth Weight; Blood Transfusion; Bronchopulmonary Dysplasia; China; Ductus Arteriosus, Patent | 2018 |
Factors affecting the efficacy and safety of aminophylline in treatment of apnea of prematurity in neonatal intensive care unit.
Topics: Aminophylline; Apnea; Birth Weight; Female; Gestational Age; Humans; Infant; Infant, Newborn; Infant | 2019 |
Variability in Immunization Practices for Preterm Infants.
Topics: Apnea; Birth Weight; Bradycardia; Gestational Age; Humans; Immunization Schedule; Infant; Infant, Lo | 2018 |
Combined effects of body position and sleep status on the cardiorespiratory stability of near-term infants.
Topics: Apnea; Birth Weight; Bradycardia; Female; Heart Rate; Humans; Infant; Infant, Newborn; Infant, Prema | 2018 |
Doxapram Treatment and Diaphragmatic Activity in Preterm Infants.
Topics: Apnea; Birth Weight; Diaphragm; Doxapram; Electromyography; Female; Gestational Age; Humans; Infant, | 2019 |
Incidence of catheter-related bloodstream infections in neonates following removal of peripherally inserted central venous catheters.
Topics: Anti-Bacterial Agents; Apnea; Birth Weight; Bradycardia; Catheter-Related Infections; Catheterizatio | 2014 |
[Exploring the clinical significance of continuously measuring apparent diffusion coefficient values in the preterm infants with punctate white matter damage by applying diffusion weighted imaging].
Topics: Apnea; Birth Weight; Brain; Brain Diseases; Case-Control Studies; Diffusion Magnetic Resonance Imagi | 2014 |
Clinico-epidemiological study of low birth weight newborns in the Eastern part of Nepal.
Topics: Apnea; Birth Weight; Female; Fetal Growth Retardation; Gestational Age; Gravidity; Humans; Incidence | 2014 |
Apnea after Routine Eye Examinations in Premature Infants.
Topics: Apnea; Birth Weight; Bradycardia; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Ophth | 2017 |
Clinically significant cardiopulmonary events and the effect of definition standardization on apnea of prematurity management.
Topics: Apnea; Birth Weight; Caffeine; Disease Management; Female; Gestational Age; Humans; Infant; Infant, | 2017 |
Effects of Breathing and Apnoea during Sustained Inflations in Resuscitation of Preterm Infants.
Topics: Apnea; Birth Weight; Delivery Rooms; Female; Gestational Age; Humans; Infant, Newborn; Infant, Prema | 2017 |
Differential diagnosis of apneas in preterm infants.
Topics: Apgar Score; Apnea; Arousal; Birth Weight; Diagnosis, Differential; Electrocardiography; Electroence | 2009 |
Time courses of intrapartum asphyxia: neonatal characteristics and outcomes.
Topics: Acidosis; Apgar Score; Apnea; Asphyxia Neonatorum; Birth Weight; Cause of Death; Child, Preschool; C | 2009 |
Retinopathy of prematurity in a tertiary care center--incidence, risk factors and outcome.
Topics: Apnea; Birth Weight; Developing Countries; Female; Gestational Age; Humans; Incidence; India; Infant | 2009 |
Developmental pattern of urinary bile acid profile in preterm infants.
Topics: Apgar Score; Apnea; Bile Acids and Salts; Birth Weight; Female; Gas Chromatography-Mass Spectrometry | 2010 |
A critical review of premature infants with inguinal hernias: optimal timing of repair, incarceration risk, and postoperative apnea.
Topics: Apnea; Birth Weight; Comorbidity; Elective Surgical Procedures; Female; General Surgery; Gestational | 2011 |
Effects of non-synchronised nasal intermittent positive pressure ventilation on spontaneous breathing in preterm infants.
Topics: Apnea; Birth Weight; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Pr | 2011 |
Predictive factors of PACU stay after herniorraphy in infant: a classification and regression tree analysis.
Topics: Analgesics; Anesthesia, General; Anesthesia, Spinal; Apnea; Birth Weight; Cohort Studies; Conscious | 2012 |
Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants.
Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Agents; Dried Blood Spot Testing; Female; Gest | 2013 |
[Analysis of apnea in 229 cases of very low birth weight infants].
Topics: Apnea; Birth Weight; China; Female; Gestational Age; Humans; Infant, Newborn; Infant, Very Low Birth | 2003 |
Postnatal risk factors of retinopathy of prematurity.
Topics: Apnea; Birth Weight; Disease Progression; Gestational Age; Humans; Infant, Newborn; Infant, Prematur | 2004 |
Screening for retinopathy of prematurity: is it painful?
Topics: Apnea; Birth Weight; Blood Pressure; Diagnostic Techniques, Ophthalmological; Gestational Age; Heart | 2004 |
Successful liver transplantation for congenital absence of the portal vein complicated by intrapulmonary shunt and brain abscess.
Topics: Abnormalities, Multiple; Anti-Bacterial Agents; Apnea; Atrophy; Birth Weight; Brain; Brain Abscess; | 2005 |
Brain hemodynamic effects of doxapram in preterm infants.
Topics: Apnea; Birth Weight; Blood Flow Velocity; Brain; Case-Control Studies; Doxapram; Gestational Age; Hu | 2006 |
Frequency of apnea, bradycardia, and desaturations following first diphtheria-tetanus-pertussis-inactivated polio-Haemophilus influenzae type B immunization in hospitalized preterm infants.
Topics: Alberta; Apnea; Birth Weight; Body Weight; Bradycardia; Child, Hospitalized; Cohort Studies; Diphthe | 2006 |
[Apnea of prematurity: risk factors and ambulatory treatment with caffeine citrate].
Topics: Ambulatory Care; Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Citrates; Continu | 2006 |
Risk factors for retinopathy of prematurity in six neonatal intensive care units in Beijing, China.
Topics: Abruptio Placentae; Anemia; Apnea; Birth Weight; China; Female; Gestational Age; Humans; Hypoxia-Isc | 2008 |
Hypoglycaemia in the newborn: diagnosis, treatment and prognosis.
Topics: Apnea; Birth Injuries; Birth Weight; Cyanosis; Female; Glucose; Humans; Hydrocortisone; Hypoglycemia | 1966 |
Current considerations in neonatal anaesthesia.
Topics: Anesthesia; Anesthetics; Apgar Score; Apnea; Birth Weight; Cardiovascular System; Central Nervous Sy | 1984 |
Acute proliferative retrolental fibroplasia: multivariate risk analysis.
Topics: Analysis of Variance; Anemia; Apnea; Birth Weight; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; | 1983 |
Risk factors in retrolental fibroplasia.
Topics: Apnea; Birth Weight; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Infant, Newborn, D | 1980 |
Deficient sympatho-adrenal activity-a cause of apnoea? Urinary excretion of catecholamines and their metabolites in preterm infants.
Topics: Adrenal Glands; Apnea; Birth Weight; Catecholamines; Epinephrine; Gestational Age; Humans; Infant, N | 1980 |
Chronic prenatal cocaine retards maturation of state and of respiratory patterns in swine.
Topics: Animals; Apnea; Birth Weight; Blood Gas Analysis; Body Temperature; Body Weight; Cocaine; Electroenc | 1995 |
OSCILLO-oscillating air mattress in neonatal care of very preterm babies.
Topics: Air; Apnea; Bedding and Linens; Birth Weight; Gestational Age; Humans; Infant, Newborn; Infant, Prem | 1995 |
Respiratory characteristics during sleep in healthy small-for- gestational age newborns.
Topics: Apnea; Birth Weight; Brain Stem; Cerebrovascular Circulation; Fetal Growth Retardation; Gestational | 1996 |
[New technique of nasal continuous positive pressure in neonatology].
Topics: Apnea; Birth Weight; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Nose; Positive-Pre | 1996 |
Influence of sleep state and respiratory pattern on cyclical fluctuations of cerebral blood flow velocity in healthy preterm infants.
Topics: Apnea; Birth Weight; Blood Flow Velocity; Cerebrovascular Circulation; Gestational Age; Humans; Infa | 1996 |
Theophylline concentration following equal doses of intravenous aminophylline and oral theophylline in preterm infants.
Topics: Administration, Oral; Aminophylline; Apnea; Birth Weight; Bronchodilator Agents; Gestational Age; Hu | 1997 |
Incidence of apnoea and bradycardia in preterm infants following DTPw and Hib immunization: a prospective study.
Topics: Apnea; Birth Weight; Bradycardia; Diphtheria-Tetanus-Pertussis Vaccine; Female; Haemophilus Vaccines | 1997 |
Complications of airway management in very-low-birth-weight infants.
Topics: Adrenal Cortex Hormones; Airway Obstruction; Apnea; Birth Weight; Bradycardia; Bronchopulmonary Dysp | 1999 |
Reduced prostacyclin to thromboxane A2 ratio is correlated with central apneas in preterm infants.
Topics: 6-Ketoprostaglandin F1 alpha; Apnea; Birth Weight; Epoprostenol; Gestational Age; Humans; Infant, Ne | 1999 |
Neonatal micrognathia is associated with small upper airways on radiographic measurement.
Topics: Apnea; Birth Weight; Craniofacial Abnormalities; Data Interpretation, Statistical; Gestational Age; | 2000 |
Apnoea of prematurity and arousal from sleep.
Topics: Apnea; Arousal; Birth Weight; Electrocardiography; Electroencephalography; Electromyography; Electro | 2001 |
Inhalation of low (0.5%-1.5%) CO2 as a potential treatment for apnea of prematurity.
Topics: Administration, Inhalation; Apnea; Birth Weight; Carbon Dioxide; Gestational Age; Humans; Infant, Ne | 2001 |
Inhalation of low (0.5%-1.5%) CO2 as a potential treatment for apnea of prematurity.
Topics: Administration, Inhalation; Apnea; Birth Weight; Carbon Dioxide; Gestational Age; Humans; Infant, Ne | 2001 |
Inhalation of low (0.5%-1.5%) CO2 as a potential treatment for apnea of prematurity.
Topics: Administration, Inhalation; Apnea; Birth Weight; Carbon Dioxide; Gestational Age; Humans; Infant, Ne | 2001 |
Inhalation of low (0.5%-1.5%) CO2 as a potential treatment for apnea of prematurity.
Topics: Administration, Inhalation; Apnea; Birth Weight; Carbon Dioxide; Gestational Age; Humans; Infant, Ne | 2001 |
Home apnea monitor use in preterm infants discharged from newborn intensive care units.
Topics: Apgar Score; Apnea; Birth Weight; Cross-Sectional Studies; Female; Gestational Age; Humans; Infant, | 2001 |
Inter-neonatal intensive care unit variation in discharge timing: influence of apnea and feeding management.
Topics: Age Factors; Apnea; Birth Weight; Body Temperature Regulation; Bradycardia; Child Development; Feedi | 2001 |
Effect of continuous positive airway pressure on breathing pattern of infants with respiratory-distress syndrome.
Topics: Apnea; Birth Weight; Blood Pressure; Bradycardia; Carbon Dioxide; Heart; Heart Rate; Humans; Infant; | 1975 |
Use of nasal continuous positive airway pressure to treat severe recurrent apnoea in very preterm infants.
Topics: Apnea; Birth Weight; Female; Gestational Age; Humans; Infant, Newborn; Male; Monitoring, Physiologic | 1976 |
Sleep state, apnea and bradycardia in pre-term infants.
Topics: Apnea; Birth Weight; Bradycardia; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infan | 1977 |
Prevention of apnea and bradycardia in low-birthweight infants.
Topics: Apnea; Birth Weight; Bradycardia; Carbon Dioxide; Female; Humans; Hydrogen-Ion Concentration; Infant | 1975 |
The influence of apnea and physical activity on arterial blood pressure and transcutaneous oxygen tension in the newborn.
Topics: Apnea; Birth Weight; Blood Gas Analysis; Blood Pressure; Body Temperature; Crying; Eating; Heart Rat | 1979 |
Three-year-old twins and singletons: a comparison of some perinatal, environmental, experiential, and developmental characteristics.
Topics: Apnea; Birth Weight; Child Development; Child, Preschool; Environment; Female; Gestational Age; Huma | 1979 |
[Theophylline for prevention of apnea in premature infants (author's transl)].
Topics: Apnea; Birth Weight; Humans; Infant, Newborn; Infant, Premature, Diseases; Tachycardia; Theophylline | 1978 |
Mechanical ventilation of infants of less than 1,501 gm birth weight: Health, growth, and neurologic sequelae.
Topics: Apnea; Birth Weight; Body Height; Child, Preschool; Female; Follow-Up Studies; Growth; Hemiplegia; H | 1976 |
Effect of exchange transfusion on elimination of theophylline in premature neonates.
Topics: Aminophylline; Apnea; Birth Weight; Dose-Response Relationship, Drug; Exchange Transfusion, Whole Bl | 1977 |
[Apnea in infants with low birth weights].
Topics: Apnea; Asphyxia Neonatorum; Birth Weight; Denmark; Humans; Infant, Newborn; Infant, Premature, Disea | 1976 |
[Apnea cases in children born with low birth weights].
Topics: Apnea; Asphyxia Neonatorum; Birth Weight; Humans; Infant, Newborn; Infant, Premature, Diseases; Resp | 1976 |
[Prognostic score of newborn infants with low birth weight].
Topics: Apnea; Birth Weight; Body Temperature; Computers; Female; Humans; Infant, Newborn; Infant, Premature | 1976 |
[Longtime artificial respiration of newborn infants using the Bird respirator].
Topics: Apnea; Asphyxia Neonatorum; Birth Weight; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases | 1976 |
Surgical closure of patent ductus arteriosus in the premature infant with respiratory distress.
Topics: Aortography; Apnea; Birth Weight; Blood Pressure; Ductus Arteriosus, Patent; Electrocardiography; Fe | 1975 |
Respiratory insufficiency syndrome (RIS) in preterm infants with gestational age of 32 weeks and less. Neonatal management and follow-up study.
Topics: Apnea; Birth Weight; Female; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Intermitte | 1975 |
Early neonatal hypocalcaemia.
Topics: Apnea; Asphyxia Neonatorum; Birth Weight; Calcium; Ductus Arteriosus, Patent; Erythroblastosis, Feta | 1975 |
[Infants of low birth weight after deliveries, morbidity and mortality (author's transl)].
Topics: Apgar Score; Apnea; Asphyxia Neonatorum; Birth Weight; Body Height; Breech Presentation; Cerebral He | 1975 |
Neonatal complications and risk of intraventricular-periventricular hemorrhage.
Topics: Acid-Base Equilibrium; Apnea; Birth Weight; Cerebral Hemorrhage; Female; Gestational Age; Humans; In | 1992 |
Methods of resuscitation in low-Apgar-score newborn infants--a national survey.
Topics: Apgar Score; Apnea; Birth Certificates; Birth Weight; Clinical Protocols; Congenital Abnormalities; | 1992 |
Apparent life-threatening events during infancy: a follow-up study of subsequent growth and development.
Topics: Apgar Score; Apnea; Birth Weight; Child Development; Child, Preschool; Female; Follow-Up Studies; Ge | 1991 |
Respiratory outcome in extremely premature infants following ketamine anaesthesia.
Topics: Age Factors; Aminophylline; Anesthesia, Intravenous; Apnea; Birth Weight; Gestational Age; Humans; I | 1991 |
Apnea, transient episodes of bradycardia, and periodic breathing in preterm infants.
Topics: Apgar Score; Apnea; Birth Weight; Bradycardia; Cheyne-Stokes Respiration; Gestational Age; Heart Rat | 1990 |
Prospective pneumogram recordings in preterm infants with and without clinical apnea and bradycardia.
Topics: Apnea; Birth Weight; Bradycardia; Gestational Age; Humans; Infant, Low Birth Weight; Infant, Newborn | 1990 |
Mechanical ventilation in newborn infants.
Topics: Apnea; Birth Weight; Female; Gestational Age; Humans; Infant, Newborn; Intermittent Positive-Pressur | 1988 |
Risk factors for retrolental fibroplasia: experience with 3,025 premature infants. National Collaborative Study on Patent Ductus Arteriosus in Premature Infants.
Topics: Anemia; Apnea; Birth Weight; Bronchopulmonary Dysplasia; Female; Histamine H1 Antagonists; Humans; I | 1985 |
Physiologic effects of doxapram in idiopathic apnea of prematurity.
Topics: Aminophylline; Apnea; Birth Weight; Blood Pressure; Carbon Dioxide; Doxapram; Gestational Age; Human | 1986 |
Magnesium therapy in premature neonates with apnea neonatorum.
Topics: Apnea; Birth Weight; Bradycardia; Drug Administration Schedule; Follow-Up Studies; Gestational Age; | 1988 |
Prognostic determinants in neonatal tetanus.
Topics: Age Factors; Apnea; Birth Weight; Female; Humans; Infant, Newborn; Male; Prognosis; Prospective Stud | 1987 |
The electrocardiogram in preterm infants with intraventricular hemorrhage and apnea.
Topics: Apnea; Birth Weight; Bradycardia; Cerebral Hemorrhage; Cerebral Ventricles; Echoencephalography; Ele | 1986 |
Effects of maternal smoking and caffeine habits on infantile apnea: a retrospective study.
Topics: Apnea; Birth Weight; Caffeine; Female; Humans; Infant, Newborn; Maternal Age; Pregnancy; Prenatal Ex | 1986 |
Risk of hypoventilation in premature infants in car seats.
Topics: Apnea; Automobiles; Birth Weight; Female; Heart Rate; Humans; Hypoventilation; Hypoxia; Infant; Infa | 1986 |
Role of theophylline in pathogenesis of necrotizing enterocolitis.
Topics: Apgar Score; Apnea; Birth Weight; Ductus Arteriosus, Patent; Enterocolitis, Pseudomembranous; Gestat | 1986 |
Epidemiological comparisons of sudden infant death syndrome with infant apnoea.
Topics: Adult; Apnea; Birth Order; Birth Weight; Child, Preschool; Female; Humans; Infant; Infant, Newborn; | 1986 |
Morbidity and mortality associated with exchange transfusion.
Topics: Apnea; Birth Weight; Bradycardia; Calcium Gluconate; Exchange Transfusion, Whole Blood; Female; Hema | 1985 |
Immediate effects of feeding on blood-gases and some cardiorespiratory functions in ill newborn infants.
Topics: Animals; Apnea; Birth Weight; Blood Pressure Determination; Blood Proteins; Carbon Dioxide; Enteral | 1974 |
Diffusion anoxia at birth.
Topics: Adult; Anesthesia, Obstetrical; Apnea; Birth Weight; Cesarean Section; Diffusion; Female; Humans; Hy | 1968 |
Delayed resorption of pulmonary alveolar fluid in the neonate.
Topics: Apnea; Birth Weight; Cardiomegaly; Cesarean Section; Female; Hematocrit; Humans; Hypoproteinemia; In | 1972 |
Periodic breathing in premature and neonatal babies: incidence, breathing pattern, respiratory gas tensions, response to changes in the composition of ambient air.
Topics: Age Factors; Air; Apnea; Birth Weight; Body Weight; Carbon Dioxide; Electrocardiography; Humans; Inf | 1973 |
Improved prognosis for infants of very low birthweight.
Topics: Anti-Bacterial Agents; Apnea; Bacterial Infections; Birth Weight; Body Temperature Regulation; Child | 1974 |
Very low birthweight and later intelligence.
Topics: Apnea; Birth Weight; Black People; Female; Fertility; Fetal Diseases; Gestational Age; Humans; Hyper | 1974 |
[Electric current as stimulus in immature babies with recurrent apneic attacks? (author's transl)].
Topics: Anti-Bacterial Agents; Apnea; Birth Weight; Burns, Electric; Electric Stimulation; Electricity; Gest | 1974 |
Neonatal at risk factors.
Topics: Apgar Score; Apnea; Birth Weight; Child Development; Child, Preschool; Follow-Up Studies; Gestationa | 1972 |
Morbidity and mortality of infants weighing less than 1,000 grams in an intensive care nursery.
Topics: Apgar Score; Apnea; Bacterial Infections; Birth Weight; Body Temperature Regulation; Central Nervous | 1972 |
Positive airway pressure in respiratory distress syndrome.
Topics: Apnea; Autopsy; Birth Weight; Carbon Dioxide; Cerebral Hemorrhage; Cerebral Ventricles; Humans; Infa | 1974 |
The relationship of apnoea and stridor in spina bifida to other unexplained infant deaths.
Topics: Age Factors; Apnea; Birth Weight; Bradycardia; Carbon Dioxide; Cyanosis; Humans; Hydrocephalus; Infa | 1974 |
The association of hypocalcemia and recurrent apnea in premature infants.
Topics: Abruptio Placentae; Apgar Score; Apnea; Birth Weight; Blood Proteins; Calcium; Female; Gestational A | 1972 |
THAM v. sodium bicarbonate in idiopathic respiratory distress syndrome.
Topics: Apnea; Autopsy; Bicarbonates; Birth Weight; Carbon Dioxide; Cerebral Hemorrhage; Female; Gestational | 1973 |
The improving outlook for the small prematurely born infant.
Topics: Apnea; Asphyxia Neonatorum; Attention Deficit Disorder with Hyperactivity; Birth Weight; Child; Chil | 1973 |
Transient cataracts in low-birth-weight infants.
Topics: Acidosis; Ampicillin; Apgar Score; Apnea; Bicarbonates; Birth Weight; Blood Pressure; Body Temperatu | 1973 |
Spinal cord damage in a newborn infant.
Topics: Apnea; Atrophy; Birth Injuries; Birth Weight; Cephalometry; Cyanosis; Female; Fetal Heart; Heart Rat | 1974 |
Ventilator therapy in the newborn. Some mechanical considerations.
Topics: Apnea; Birth Weight; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Methods; | 1970 |
Periodic breathing and apnea in preterm infants. I. Evidence for hypoventilation possibly due to central respiratory depression.
Topics: Apnea; Birth Weight; Carbon Dioxide; Chemoreceptor Cells; Cheyne-Stokes Respiration; Female; Gestati | 1972 |
Periodic breathing and apnea in preterm infants. II. Hypoxia as a primary event.
Topics: Apnea; Birth Weight; Carbon Dioxide; Cheyne-Stokes Respiration; Female; Gestational Age; Heart Rate; | 1972 |
Epidemic listeriosis in the newborn.
Topics: Apnea; Birth Weight; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Listeriosis; Lung; | 1971 |
Artificial ventilation in respiratory failure in the newborn.
Topics: Age Factors; Apnea; Australia; Birth Weight; Gestational Age; Humans; Infant, Newborn; Infant, Newbo | 1971 |
The pre-term baby.
Topics: Anemia; Apnea; Birth Weight; Cerebral Hemorrhage; Enterocolitis, Pseudomembranous; Gestational Age; | 1971 |
[Experiences in apparative respiration control in premature and mature newborn infants].
Topics: Apgar Score; Apnea; Bilirubin; Birth Weight; Gestational Age; Humans; Infant, Newborn; Infant, Prema | 1971 |
[Indications for exchange transfusions in premature infants].
Topics: Acidosis, Respiratory; Apnea; Birth Weight; Exchange Transfusion, Whole Blood; Female; Humans; Hyper | 1969 |
Apnea in premature infants and incubator-air-temperature changes.
Topics: Air; Apnea; Birth Weight; Body Temperature; Body Temperature Regulation; Environmental Exposure; Fem | 1970 |
Indications for mechanical ventilation in infants with hyaline membrane disease.
Topics: Apnea; Autopsy; Birth Weight; Blood; Carbon Dioxide; Female; Follow-Up Studies; Gestational Age; Hea | 1970 |
Clinical indications for mechanical ventilation in newborn infants.
Topics: Apnea; Asphyxia Neonatorum; Birth Weight; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, | 1970 |
Results of artificial ventilation. Experience at the Hospital for Sick Children, Toronto.
Topics: Age Factors; Apnea; Birth Weight; Body Temperature; Female; Humans; Infant Mortality; Infant, Newbor | 1970 |
Low birth weight and intensive care.
Topics: Apnea; Birth Weight; Female; Fetal Death; Gestational Age; Humans; Infant Mortality; Infant, Newborn | 1970 |
Association of hypoglycaemia with symptoms in the newborn.
Topics: Adolescent; Adult; Apnea; Birth Weight; Factor Analysis, Statistical; Female; Hemorrhage; Humans; Hy | 1968 |
[Primary resuscitation of newborn].
Topics: Acidosis; Alkalies; Alkalosis; Apnea; Birth Weight; Electroencephalography; Humans; Infant, Newborn; | 1968 |
Apnea in premature infants: monitoring, incidence, heart rate changes, and an effect of environmental temperature.
Topics: Apnea; Birth Weight; Bradycardia; Carbon Dioxide; Cyanosis; Heart Rate; Humans; Infant, Newborn; Inf | 1969 |
Evidence of non-genetic origin of coarctation of the aorta.
Topics: Aortic Coarctation; Apnea; Birth Weight; Body Height; Child; Child, Preschool; Diseases in Twins; Fe | 1969 |
Prematurity: observations upon its current significance and management.
Topics: Apnea; Attitude to Health; Australia; Birth Weight; Communication; Cyanosis; Female; Fetal Death; Gl | 1969 |
Perinatal and environmental factors in late neurogenic sequelae. I. Infants having birth weights under 1,500 grams.
Topics: Apnea; Birth Weight; Child; Child, Preschool; Environment; Female; Follow-Up Studies; Humans; Infant | 1966 |